Top-News
USA

Quest Diagnostics Aktie

Aktie
WKN:  904533 ISIN:  US74834L1008 US-Symbol:  DGX
144,15 €
+1,75 €
+1,23%
30.10.24
Handeln Depot/Watchlist
Aktienanzahl *
112,44 Mio.
Marktkapitalisierung *
16,15 Mrd. €
Streubesitz
40,19%
Index-Zugehörigkeit
S&P 500
IR-Website
zur Website
*Stand: 08.11.2023
Weiter aufwärts? Long handeln - Jetzt mit Hebel 6,77: ME92D5
Werbung

Quest Diagnostics News

23.10.24 - PR Newswire
Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development
Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development PR Newswire
22.10.24 - PR Newswire
Quest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024
Quest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024 PR Newswire
15.10.24 - PR Newswire
Quest Diagnostics Introduces Specimen Self-Collection for Common Genital Tract Infection Testing at Nationwide Network of Patient Service Centers
Quest Diagnostics Introduces Specimen Self-​Collection for Common Genital Tract Infection Testing at Nationwide Network of Patient Service Centers PR Newswire
14.10.24 - PR Newswire
Quest Diagnostics Completes Acquisition of Lab Assets from OhioHealth
Quest Diagnostics Completes Acquisition of Lab Assets from OhioHealth PR Newswire
25.09.24 - PR Newswire
Quest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024
Quest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024 PR Newswire
18.09.24 - PR Newswire
Sentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast
Sentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast PR Newswire
16.09.24 - PR Newswire
Quest Diagnostics Completes Acquisition of Select Lab Assets from Allina Health
Quest Diagnostics Completes Acquisition of Select Lab Assets from Allina Health PR Newswire
28.08.24 - PR Newswire
Quest Diagnostics to Speak at the Morgan Stanley 22nd Annual Global Healthcare Conference
Quest Diagnostics to Speak at the Morgan Stanley 22nd Annual Global Healthcare Conference PR Newswire
26.08.24 - PR Newswire
Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation PR Newswire
21.08.24 - PR Newswire
Quest Diagnostics to Acquire University Hospitals' Outreach Laboratory Services Business
Quest Diagnostics to Acquire University Hospitals' Outreach Laboratory Services Business PR Newswire
15.08.24 - PR Newswire
Quest Diagnostics Prices $1.85 Billion of Senior Notes
Quest Diagnostics Prices $1.85 Billion of Senior Notes PR Newswire
15.08.24 - PR Newswire
questhealth.com Introduces 13 New Blood Tests to Identify Micronutrient Deficiencies
questhealth.com Introduces 13 New Blood Tests to Identify Micronutrient Deficiencies PR Newswire
14.08.24 - PR Newswire
Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics Declares Quarterly Cash Dividend PR Newswire
12.08.24 - PR Newswire
Pregnant Women Undertested for STIs, Finds Quest Diagnostics Health Trends® Study of Over 4 Million Pregnancies
Pregnant Women Undertested for STIs, Finds Quest Diagnostics Health Trends® Study of Over 4 Million Pregnancies PR Newswire
01.08.24 - PR Newswire
Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Seventh Straight Year
Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Seventh Straight Year PR Newswire
29.07.24 - PR Newswire
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal ...
25.07.24 - PR Newswire
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire
23.07.24 - PR Newswire
Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 PR Newswire
10.07.24 - PR Newswire
Quest Diagnostics to Acquire Outreach Laboratory Services of OhioHealth
Quest Diagnostics to Acquire Outreach Laboratory Services of OhioHealth PR Newswire
06.07.24 - Small- & Micro Cap Investment
KI-Markt auf Wachs­tums­kurs: CrowdStrike, Adcore, Quest Diagnostics
Der Markt für Künstliche Intelligenz (KI) erlebt ein explosives Wachstum. Laut Prognosen der Marktforschungsgesellschaft Precedence Research wird das Marktvolumen von 2023 ...

Newssuche

Videos

newspaper
31.10.24 -11,51%
Technical Trading: 83% Trefferquote für diesen Trade
Nasdaq Long Typ: Turbo Open End WKN: VM433C Hebel: 5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »
Anzeige

Aktie im Fokus

1.000 % Chance
Desert Gold Ventures Inc.
0,0465 €
-15,5%
Desert Gold Ventures Inc. Chart
Neuer Gold Rekord bei knapp 2.800 USD und Übernahme-Zirkus!
Mehr zur Aktie »